CD200 R1

CD200 R1 분자 정보

영어 이름Cell surface glycoprotein CD200 receptor 1시판 약물 수0
임상 약물 수4표적 별명Cell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
최고 연구 개발 단계Phase 2 Clinical
영어 이름Cell surface glycoprotein CD200 receptor 1
표적 별명Cell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
시판 약물 수0
임상 약물 수4
최고 연구 개발 단계Phase 2 Clinical

CD200 R1 제품 목록

  • 속성

    Protein (2)

  • 제품 라이브러리

    온라인 (2)

  • Human (2)

  • 태그

    Fc Tag & Avi Tag (1)His Tag (1)

  • 마커

    Biotin-labeled (1)Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
Human
HEK293
Human CD200 R1 / CRTR2 Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
Biotinylated Human CD200 R1 / CRTR2 Protein, Fc,Avitag™
총 수량2
  • 1

CD200 R1분자 배경

Cell surface glycoprotein CD200 receptor 1 is a protein that in humans is encoded by the CD200R1 gene. This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. CD200 and its receptor CD200R are both type-1 membrane glycoproteins, which are members of the immunoglobulin superfamily (IgSF). Besides the inhibitory effect on macrophages, CD200/CD200R also play an important role in regulating the regulatory T cells, allergicreaction, autoimmune diseases, allograft, neurological diseases and other autoimmune-related diseases. The interaction between CD200, which is mainly present in neurons but also in astrocytes, and CD200R1, which is mainly present in microglia, is one of the mechanisms involved in keeping the microglial proinflammatory phenotype under control in physiological conditions. Alterations in the expression of CD200 and CD200R1 have been described in neurodegenerative diseases, but little is known about the mechanism of regulation of these proteins under physiological or pathological conditions.

CD200 R1분자 별명

CD200R,CRTR2,MOX2R,OX2R

라이선싱 협력

프로젝트 이름약물 유형치료 영역적응증단계권리 지역
High selective OX1R/OX2R dual inhibitor treating insomniaSmall moleculeNeurological diseaseInsomniaPhase IGlobal

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
P-00623ME-00610; P-006; 23ME’610Phase 2 Clinical23andme IncCarcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
상세
GS-5305GS-5305Phase 1 ClinicalGilead Sciences LdaInflammation
상세
DS-234DS-234; ARQ-234Phase 1 ClinicalDucentis BioTherapeutics LtdDermatitis, Atopic; Eczema
상세
UcenprubartLY-3454738Phase 1 ClinicalEli Lilly And CompanyChronic Urticaria; Dermatitis, Atopic
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호